- Home
- USAS vs KURA Comparison
USAS vs KURA Comparison
Compare USAS & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- KURA
- Stock Information
- Founded
- USAS 1998
- KURA 2014
- Country
- USAS Canada
- KURA United States
- Employees
- USAS N/A
- KURA N/A
- Industry
- USAS Metal Mining
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USAS Basic Materials
- KURA Health Care
- Exchange
- USAS Nasdaq
- KURA Nasdaq
- Market Cap
- USAS 536.1M
- KURA 561.9M
- IPO Year
- USAS N/A
- KURA N/A
- Fundamental
- Price
- USAS $0.85
- KURA $5.60
- Analyst Decision
- USAS Strong Buy
- KURA Strong Buy
- Analyst Count
- USAS 1
- KURA 12
- Target Price
- USAS $1.00
- KURA $24.50
- AVG Volume (30 Days)
- USAS 2.0M
- KURA 1.3M
- Earning Date
- USAS 08-14-2025
- KURA 08-07-2025
- Dividend Yield
- USAS N/A
- KURA N/A
- EPS Growth
- USAS N/A
- KURA N/A
- EPS
- USAS N/A
- KURA N/A
- Revenue
- USAS $102,883,000.00
- KURA $67,991,000.00
- Revenue This Year
- USAS $45.78
- KURA $109.86
- Revenue Next Year
- USAS $17.98
- KURA $107.90
- P/E Ratio
- USAS N/A
- KURA N/A
- Revenue Growth
- USAS 8.12
- KURA N/A
- 52 Week Low
- USAS $0.21
- KURA $5.41
- 52 Week High
- USAS $0.90
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- USAS 67.28
- KURA 37.63
- Support Level
- USAS $0.72
- KURA $5.73
- Resistance Level
- USAS $0.85
- KURA $6.01
- Average True Range (ATR)
- USAS 0.05
- KURA 0.29
- MACD
- USAS -0.00
- KURA -0.08
- Stochastic Oscillator
- USAS 98.39
- KURA 1.57
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.